TPEX:4139

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Ma Kuang Healthcare Holding

Market Cap

NT$2.3b

Last Updated

2021/06/18 08:52 UTC

Data Sources

Company Financials

Executive Summary

Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan. More Details


Snowflake Analysis

Excellent balance sheet and slightly overvalued.

Share Price & News

How has Ma Kuang Healthcare Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4139 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: 4139's weekly volatility (2%) has been stable over the past year.


Market Performance


7 Day Return

0.2%

4139

-0.1%

TW Healthcare

1.3%

TW Market


1 Year Return

-15.8%

4139

11.8%

TW Healthcare

48.5%

TW Market

Return vs Industry: 4139 underperformed the TW Healthcare industry which returned 11.9% over the past year.

Return vs Market: 4139 underperformed the TW Market which returned 48.1% over the past year.


Shareholder returns

4139IndustryMarket
7 Day0.2%-0.1%1.3%
30 Day0.2%3.1%8.1%
90 Day-2.9%1.1%8.0%
1 Year-13.9%-15.8%15.3%11.8%53.3%48.5%
3 Year-14.6%-16.5%46.9%32.6%75.9%55.7%
5 Year26.1%23.2%78.5%48.6%140.8%97.9%

Long-Term Price Volatility Vs. Market

How volatile is Ma Kuang Healthcare Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Ma Kuang Healthcare Holding undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 4139 (NT$53.2) is trading below our estimate of fair value (NT$555.56)

Significantly Below Fair Value: 4139 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 4139 is poor value based on its PE Ratio (27.2x) compared to the TW Healthcare industry average (16.8x).

PE vs Market: 4139 is poor value based on its PE Ratio (27.2x) compared to the TW market (17.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4139's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 4139 is overvalued based on its PB Ratio (4x) compared to the TW Healthcare industry average (1.9x).


Future Growth

How is Ma Kuang Healthcare Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ma Kuang Healthcare Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Ma Kuang Healthcare Holding performed over the past 5 years?

68.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4139 has high quality earnings.

Growing Profit Margin: 4139's current net profit margins (8.9%) are lower than last year (8.9%).


Past Earnings Growth Analysis

Earnings Trend: 4139 has become profitable over the past 5 years, growing earnings by 68% per year.

Accelerating Growth: 4139's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4139 had negative earnings growth (-7.2%) over the past year, making it difficult to compare to the Healthcare industry average (-2.6%).


Return on Equity

High ROE: 4139's Return on Equity (15.9%) is considered low.


Financial Health

How is Ma Kuang Healthcare Holding's financial position?


Financial Position Analysis

Short Term Liabilities: 4139's short term assets (NT$537.2M) exceed its short term liabilities (NT$443.8M).

Long Term Liabilities: 4139's short term assets (NT$537.2M) exceed its long term liabilities (NT$327.9M).


Debt to Equity History and Analysis

Debt Level: 4139's debt to equity ratio (61.9%) is considered high.

Reducing Debt: 4139's debt to equity ratio has reduced from 78.4% to 61.9% over the past 5 years.

Debt Coverage: 4139's debt is well covered by operating cash flow (71.1%).

Interest Coverage: 4139's interest payments on its debt are well covered by EBIT (6.4x coverage).


Balance Sheet


Dividend

What is Ma Kuang Healthcare Holding current dividend yield, its reliability and sustainability?

3.01%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4139's dividend (3.01%) is higher than the bottom 25% of dividend payers in the TW market (2.04%).

High Dividend: 4139's dividend (3.01%) is low compared to the top 25% of dividend payers in the TW market (5.01%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether 4139's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 4139's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: At its current payout ratio (81.9%), 4139's payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

11.1yrs

Average board tenure


CEO

Chuan-Sheng Huang

21.17yrs

Tenure

NT$1,411,000

Compensation

Mr. Chuan-Sheng Huang serves as Chief Executive Officer, and Founder of Ma Kuang Healthcare Group Pte Ltd. and its General Manager since August 9, 2018. Mr. Huang has been President for Ma Kuang Healthcare...


Board Members

Experienced Board: 4139's board of directors are seasoned and experienced ( 11.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ma Kuang Healthcare Holding Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ma Kuang Healthcare Holding Limited
  • Ticker: 4139
  • Exchange: TPEX
  • Founded: 2009
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: NT$2.264b
  • Shares outstanding: 42.55m
  • Website: https://www.makuanggroup.com

Number of Employees


Location

  • Ma Kuang Healthcare Holding Limited
  • Harbour Centre
  • 3rd Floor
  • George Town
  • Grand Cayman
  • Cayman Islands

Listings


Biography

Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan. The company offers TCM healthcare services, such as TCM orthopedic, weight management, pain management,...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/18 08:52
End of Day Share Price2021/06/17 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.